Showing 4901-4910 of 5771 results for "".
- New Funding for Orbis International Will Increase Global Access to Eye Care Through Technologyhttps://modernod.com/news/new-funding-for-orbis-international-will-increase-global-access-to-eye-care-through-technology/2477136/This Giving Tuesday, Orbis International announced the launch of its Silicon Valley Orbis Innovation Fund, which seeks to raise $8 million in donations to harness the next generation of technology that will revolutionize the future of e
- Study Shows Superior Success Rate for ExTra ELT Compared With Trabectome in Patients With Glaucoma Plus Cataract Surgeryhttps://modernod.com/news/study-shows-superior-success-rate-for-extra-elt-compared-with-trabectome-in-patients-with-glaucoma-plus-cataract-surgery/2477135/ELT Sight announced that in the largest published study to date on excimer laser trabeculostomy (ELT), the ExTra ELT procedure plus cataract surgery was superior to ab interno trabeculectomy with the Trabectome plus cataract surgery, according to a company news release. The 245-patient
- RightEye Vision System Receives Breakthrough Device Designation from the FDA for Parkinson’s Disease Testhttps://modernod.com/news/righteye-vision-system-receives-breakthrough-device-designation-from-the-fda-for-parkinsons-disease-test/2477133/RightEye announced that the RightEye Vision System has received breakthrough device designation from the FDA for a Parkinson’s Disease Test. The designation is designed to streamline the market clearance
- Johnson & Johnson Vision Introduces Tecnis Toric II 1-Piece IOL as New Monofocal Option for Patients with Astigmatismhttps://modernod.com/news/johnson-johnson-vision-introduces-tecnis-toric-ii-1-piece-iol-as-new-monofocal-option-for-patients-with-astigmatism/2477134/Johnson & Johnson Vision announced the FDA approval and US launch of Tecnis Toric II 1-Piece IOL. This is the first product approved on the new Tecnis Toric II platform, which offers more surface texture and friction on the IOL haptics to hold an IOL in proper position within the eye, accordi
- NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.comhttps://modernod.com/news/novabay-pharmaceuticals-launches-novawipes-eyelid-wipes-on-amazon-com/2477129/NovaBay Pharmaceuticals announced the launch of NovaWipes, a dry, soft, hypoallergenic and absorbable wipe for use in applying Avenova, on Amazon.com. Avenova Direct, NovaBay’s prescription-strength lid and lash spray, is also available on Amazon.com without a prescription. “Our soft and a
- Positive Phase 3 Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum Disorder Published in NEJMhttps://modernod.com/news/positive-phase-3-results-for-genentechs-satralizumab-in-neuromyelitis-optica-spectrum-disorder-published-in-nejm/2477130/Genentech announced that data from SAkuraSky, a pivotal phase 3 study of the investigational medicine satralizumab for the treatment of neuromyelitis optica spectrum disorder (NMOSD), were published in the November 27, 2019 online issue of the New England Journal of Medicine (NEJM).
- Mark McGrath to Headline Celebration at Optometry’s Meeting 2020https://modernod.com/news/mark-mcgrath-to-headline-celebration-at-optometrys-meeting-2020/2477126/The American Optometric Association has announced that it is celebrating the decade of the 90s at its annual Optometry’s Meeting, June 24-28, in National Harbor, Maryland/Washington, D.C. “Mark McGrath’s ’90s Experience” will headline the closing Celebration o
- Iveric bio Appoints Guangping Gao, PhD, Internationally Recognized Gene Therapy Pioneer as Chief Strategist, Gene Therapyhttps://modernod.com/news/iveric-bio-appoints-guangping-gao-phd-internationally-recognized-gene-therapy-pioneer-as-chief-strategist-gene-therapy/2477122/Iveric bio announced the appointment of Guangping Gao, PhD, as Chief Strategist, Gene Therapy. Dr. Gao brings more than 30 years of scientific research experience in gene-based treatments. As one of the world’s leading gene therapy experts, Dr. Gao’s highly distinguished career includes major con
- Ophthalmic Laser Market Expected to Total $406 Million in 2019https://modernod.com/news/ophthalmic-laser-market-expected-to-total-406-million-in-2019/2477117/Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compound annual rate of 1.6 percent from 2019 to 2024, according to Market Scope estimates. Factor
- Horizon Therapeutics Launches New Online Community Connecting People Living With Thyroid Eye Diseasehttps://modernod.com/news/horizon-therapeutics-launches-new-online-community-connecting-people-living-with-thyroid-eye-disease/2477116/Horizon Therapeutics announced the launch of “Listen to Your Eyes,” a new